Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07535359 |
| Title | Medical Access Program for Ifinatamab Deruxtecan in 3L+ Pretreated Extensive-stage Small Cell Lung Cancer |
| Recruitment | Available |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | No |
| Sponsors | Daiichi Sankyo |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Health Partners Oncology | AVAILABLE | Saint Paul | Minnesota | 55101 | United States | Details |
| Citizens Memorial Hospital | AVAILABLE | Bolivar | Missouri | 65613 | United States | Details |
| Duke Cancer Institute | AVAILABLE | Durham | North Carolina | 27710 | United States | Details |
| Baptist Cancer Center | AVAILABLE | Memphis | Tennessee | 38120 | United States | Details |
| University of Texas Southwestern Medical | AVAILABLE | Dallas | Texas | 75390 | United States | Details |